ArticleFrontiers in immunology2023

Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.